NCT04461509 2026-02-20
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Cedars-Sinai Medical Center
Phase 2 Completed
Clinical Trials
20 trialsNCT03543189 2026-01-29
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute
Phase 1/2 Active not recruiting
NCT00853710 2025-11-20
Test Semiquantitative Prostate Specific Antigen (PSA)
Institut Curie
Phase NA Completed
NCT07130708 2025-08-19
Exploring the Potential of Robotic Telesurgery in Remote Settings
AdventHealth
Phase NA Recruiting
NCT05574647 2025-07-24
IP7-PACIFIC
Imperial College London
Phase NA Recruiting
NCT05902637 2025-02-25
MAPROSTATE
Marmara University
Phase NA Completed
NCT06496581 2024-12-20
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
UNICANCER
Phase 3 Recruiting
NCT00946881 2024-02-07
Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 1/2 Completed
NCT04599218 2024-02-02
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer
Northwell Health
Phase NA Unknown
NCT04656678 2024-02-02
Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer
Northwell Health
Phase NA Unknown
NCT05150236 2023-12-15
ANZUP2001
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Unknown
NCT04880681 2023-05-01
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
Phase NA Unknown
NCT05834270 2023-04-28
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH
Menoufia University
Phase NA Completed
NCT04831307 2021-12-03
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
British Columbia Cancer Agency
Phase NA Unknown
NCT04225299 2020-11-13
Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer
Steba Biotech S.A.
Phase 3 Withdrawn
NCT04462926 2020-09-17
PSMA-PROSTAPET
Azienda Ospedaliero-Universitaria di Modena
Phase NA Unknown
NCT01310894 2019-07-11
PCM301
Steba Biotech S.A.
Phase 3 Completed
NCT00672009 2018-10-24
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Cedars-Sinai Medical Center
Phase 2 Terminated
NCT01307852 2016-04-06
In Vivo Dosimetry During Prostate Cancer Radiotherapy
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00975429 2015-04-28
Study Using WST11 in Patients With Localized Prostate Cancer
Steba Biotech S.A.
Phase 2 Completed